• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

Recent Advances in Pyrimidine-4,6-diamine (CAS: 2434-56-2) Research: A Comprehensive Review

Pyrimidine-4,6-diamine (CAS: 2434-56-2) has emerged as a pivotal compound in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. Recent studies have highlighted its potential as a core scaffold for designing novel therapeutic agents, particularly in the treatment of infectious diseases and cancer. This research briefing aims to synthesize the latest findings on pyrimidine-4,6-diamine, focusing on its chemical properties, biological activities, and therapeutic applications.

One of the most significant breakthroughs in recent research involves the optimization of pyrimidine-4,6-diamine derivatives for enhanced pharmacokinetic properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that structural modifications at the 2- and 5-positions of the pyrimidine ring significantly improved the compound's bioavailability and target specificity. These modifications were achieved through a combination of computational modeling and high-throughput screening, yielding derivatives with potent inhibitory effects against bacterial DNA gyrase, a key target in antibiotic development.

In the context of anticancer research, pyrimidine-4,6-diamine has shown promise as a modulator of cell cycle regulators. A recent preclinical study revealed that certain derivatives of this compound selectively inhibit cyclin-dependent kinases (CDKs), particularly CDK4 and CDK6, which are often dysregulated in various cancers. The study, conducted by a team at the National Cancer Institute, reported a 60% reduction in tumor growth in murine models following treatment with a pyrimidine-4,6-diamine-based CDK inhibitor. These findings underscore the compound's potential as a scaffold for developing next-generation targeted cancer therapies.

Another area of active investigation is the application of pyrimidine-4,6-diamine in antiviral drug development. Researchers have identified several derivatives that exhibit potent activity against RNA viruses, including SARS-CoV-2 and influenza. A 2024 study in Antiviral Research described a novel pyrimidine-4,6-diamine analog that inhibits viral RNA polymerase with an IC50 value of 0.8 μM, representing a significant improvement over existing polymerase inhibitors. The compound's mechanism of action involves binding to a conserved region of the polymerase, thereby reducing the likelihood of viral resistance development.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and sustainable routes for pyrimidine-4,6-diamine production. A green chemistry approach published in Organic Process Research & Development in 2023 reported a one-pot synthesis method that reduces waste generation by 40% compared to traditional methods. This innovation not only improves the environmental footprint of production but also enhances the scalability of pyrimidine-4,6-diamine-based drug development.

Looking forward, the research community anticipates several exciting directions for pyrimidine-4,6-diamine studies. These include exploring its potential in combination therapies, investigating its role in epigenetic modulation, and developing novel formulations to overcome current limitations in drug delivery. As the understanding of this compound's pharmacological profile continues to expand, it is poised to make significant contributions to addressing unmet medical needs across multiple therapeutic areas.

• 591-54-8(pyrimidin-4-amine)
• 5468-67-7(pyrimidine-4,6-diamine hydrochlo)
• 176773-06-1(4(3H)-Pyrimidinimine,(Z)- (9CI))
• 176773-07-2(4(3H)-Pyrimidinimine,(E)- (9CI))
• 163133-87-7(4(3H)-Pyrimidinimine)
• 156-81-0(pyrimidine-2,4-diamine)
• 114632-31-4(Pyrimidinediamine)
• 176772-96-6(4(1H)-Pyrimidinimine,(E)- (9CI))
• 176799-58-9(4(1H)-Pyrimidinimine,(Z)- (9CI))
• 163133-86-6(4(1H)-Pyrimidinimine)